Collaboration between Vivun and Presales Collective to Revolutionize the Future of Presales Joint Manifesto Offers New Title and Organizational Structure for the Profession OAKLAND, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) — Vivun and PreSales Collective have joined forces to rethink the future of the PreSales profession In an industry-first collaboration, Vivun and PreSales Collective are…
Dr. Robert Barnes: The Man Behind the Innovation Introducing Appital Turquoise BookBuilder™ The Future of Buy-Side Investing Dr. Robert Barnes, Group Head of Securities Trading & CEO Turquoise Global Holdings at London Stock Exchange Group, has made waves in the financial world with the introduction of Appital Turquoise BookBuilder™. This groundbreaking innovation revolutionizes the way…
NinjaTrader Group Welcomes New CTO: Meet Hazim Macky, Former VP of Engineering at Coinme! If you’re a fan of trading software and futures brokerage services, then you’ll be interested to hear about the latest news from NinjaTrader Group. The company, which is known for its innovative trading software, has just announced the appointment of Hazim…
Welcome to the Quirky World of Lowell Farms Inc. A New Chapter for Lowell Farms Inc. Picture this: the sun is shining, the birds are chirping, and Lowell Farms Inc. is making headlines once again. That’s right, folks – Lowell Farms Inc., the California-born innovator in cannabis cultivation, has just announced the closing of a…
Welcome to the Wonderful World of Trade Surpluses and Deficits! A Surplus Emerges The non-seasonally adjusted figure also sees a return to surplus of €3.2 billion, from -€15.4 billion previously. It is a welcome development after higher energy and raw material prices led the current account to a deficit in the prior two months. That…
Revolutionizing Oncology Clinical Trials Accelerating Patient Enrollment for the Benefit of Oncology Patients Science 37 and Syapse: A Game-Changing Partnership Oncology clinical trials have long been plagued by slow patient enrollment, leading to delays in the development of innovative treatments and therapies. However, a recent partnership between Science 37 and Syapse is set to revolutionize…
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update PCS12852 on target to complete enrollment by September Expanded efforts to increase enrollment in PCS499 and PCS6422 showing results Exciting news for Processa Pharmaceuticals, Inc. as they announce their second quarter 2022 financial results and provide a corporate update. With PCS12852 on track…
Cerevel Therapeutics Announces Pricing of $300 Million Private Offering of Convertible Senior Notes What is Cerevel Therapeutics? Cerevel Therapeutics Holdings, Inc. is a company based in Cambridge, Massachusetts that is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. Their mission is to develop innovative treatments for conditions that affect the brain…
